G. Lee

发表

Structure−Activity Relationship Studies of Spinorphin as a Potent and Selective Human P2X3 Receptor Antagonist

Yong‐Chul Kim, Chul-Seung Park, Hyun-Ho Lim, 2007 .

Structure-activity relationship studies of spinorphin as a potent and selective human P2X(3) receptor antagonist.

Yong‐Chul Kim, Chul-Seung Park, Hyun-Ho Lim, 2007, Journal of medicinal chemistry.

Synthesis and structure-activity relationships of novel, substituted 5,6-dihydrodibenzo[a,g]quinolizinium P2X7 antagonists.

Yong‐Chul Kim, ho-sung Lee, Won-Ki Kim, 2009, Bioorganic & medicinal chemistry letters.

Electrophysiological Characterization of Benzofuroindole-Induced Potentiation of Large-Conductance Ca2+-Activated K+ Channels

Chul-Seung Park, Hyun-Ho Lim, T. Ha, 2006, Molecular Pharmacology.

Stimulation of the P2X7 receptor kills rat retinal ganglion cells in vivo.

K. Jacobson, A. Laties, Yong‐Chul Kim, 2010, Experimental eye research.

Potent Suppressive Effects of 1-Piperidinylimidazole Based Novel P2X7 Receptor Antagonists on Cancer Cell Migration and Invasion.

Darren R. Williams, C. Müller, Jeong-min Lee, 2016, Journal of medicinal chemistry.

Characterization of Benzofuroindole-Induced Potentiation of Large-conductance Ca 2 +-activated K + Channels

Chul-Seung Park, Hyun-Ho Lim, T. Ha, 2005 .

Characterization of protoberberine analogs employed as novel human P2X7 receptor antagonists.

Chul-Seung Park, Sunghoe Chang, Won-Gil Lee, 2011, Toxicology and applied pharmacology.

Discovery of novel 2,5-dioxoimidazolidine-based P2X(7) receptor antagonists as constrained analogues of KN62.

K. Kang, Sung-Chul Lim, Yong‐Chul Kim, 2015, Journal of medicinal chemistry.

Synthesis and structure-activity relationship studies of tyrosine-based antagonists at the human P2X7 receptor.

K. Jacobson, H. Moon, Yong‐Chul Kim, 2008, Bioorganic & medicinal chemistry letters.

Structure-activity relationship studies of pyrimidine-2,4-dione derivatives as potent P2X7 receptor antagonists.

Yong‐Chul Kim, Jin-Hee Park, H. Ko, 2015, European journal of medicinal chemistry.

Corrigendum to “Synthesis and structure–activity relationship studies of tyrosine-based antagonists at the human P2X7 receptor” [Bioorg. Med. Chem. Lett. 18 (2008) 571–575]

K. Jacobson, H. Moon, L. Jeong, 2009 .

Establishment of an assay for P2X7 receptor-mediated cell death.

L. Jeong, Chul-Seung Park, Yong-chul Kim, 2006, Molecules and cells.

Discovery of novel 2,5-dioxoimidazolidine-based P2X(7) receptor antagonists as constrained analogues of KN62.

K. Kang, Sung-Chul Lim, Jin-Hee Park, 2015, Journal of medicinal chemistry.